Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China · Delayed Price · Currency is CNY 37.08
+0.91 (2.52%)
Jul 15, 2026, 3:00 PM CST
Hangzhou Biotest Biotech Market Cap
Hangzhou Biotest Biotech has a market cap or net worth of 5.29 billion as of July 14, 2026. Its market cap has increased by 4.93% in one year.
Market Cap
5.29B
Enterprise Value
3.89B
Revenue
449.50M
Ranking
n/a
PE Ratio
172.94
Stock Price
37.08
Market Cap Chart
Since September 8, 2021, Hangzhou Biotest Biotech's market cap has decreased from 8.23B to 5.29B, a decrease of -35.67%. That is a compound annual growth rate of -8.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 5.29B | -4.26% |
| Dec 31, 2025 | 5.53B | 60.13% |
| Dec 31, 2024 | 3.45B | 6.92% |
| Dec 29, 2023 | 3.23B | -34.48% |
| Dec 30, 2022 | 4.93B | -33.91% |
| Dec 31, 2021 | 7.46B | -9.37% |
| Sep 8, 2021 | 8.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Youcare Pharmaceutical Group | 6.20B |
| Chengdu Kanghua Biological Products | 6.20B |
| Shouyao Holdings (Beijing) Co., LTD. | 6.11B |
| Xiangxue Pharmaceutical | 6.06B |
| Jiangsu Aidea Pharmaceutical Group | 6.03B |
| Wuhan Keqian Biology Co.,Ltd | 5.96B |
| PharmaResources (Shanghai) | 5.52B |
| Novogene | 5.32B |